Net margin · 2017–2025

Nutex Health net margin

8.1%−25.5% · FY2025

Nutex Health (NUTX) reported 8.1% in net margin for fiscal 2025, −25.5% year on year.

2,512.6%2017−69.5%2018−520.8%201938.7%202040.0%2021−193.7%2022−18.5%202310.9%20248.1%2025
Nutex Health — Net margin, 2017–2025
Fiscal yearNet marginChangeFiling
FY20258.1%−25.5%Derived
FY202410.9%+29.3 ppDerived
FY2023−18.5%+175.2 ppDerived
FY2022−193.7%−233.7 ppDerived
FY202140.0%+3.4%Derived
FY202038.7%+559.5 ppDerived
FY2019−520.8%−451.3 ppDerived
FY2018−69.5%−2,582.1 ppDerived
FY20172,512.6%—Derived

Net margin — Net margin is net income divided by revenue. Only companies with at least $1 billion in revenue are ranked here: a small company can post an extreme margin that tells you nothing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth −51.2%

Calculated from two reported figures, so it has no single filing of its own.

Net margin at companies of similar size

Full ranking by net margin →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Nutex Health net margin |url=https://companiesranked.com/en/company/nutex-health/net-profit-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Nutex Health net margin. CompaniesRanked. https://companiesranked.com/en/company/nutex-health/net-profit-margin

BibTeX

@misc{companiesranked-en-company-nutex-health-net-profit-margin-2026,
  author       = {{CompaniesRanked}},
  title        = {{Nutex Health net margin}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/nutex-health/net-profit-margin}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Nutex Health overview